OPKO Health (OPK) Tops Q2 EPS by 4c, beats revenue
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- Nasdaq futures sink as AI doubts resurface, oil jumps
- Oil jumps on escalating Middle East conflict
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- JPMorgan says AI stock selling may be nearing its limit as positioning resets
Tweet
Share
E-mail
Get Alerts OPK Hot Sheet
Price: $1.60 --0%
EPS Growth %: -333.3%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
SICP, MNSB, CFFI, More
EPS Growth %: -333.3%
Financial Fact:
Research and development: 24.42M
Today's EPS Names:
SICP, MNSB, CFFI, More
Join SI Premium – FREE
OPKO Health (NASDAQ: OPK) reported Q2 EPS of ($0.03), $0.04 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $265.4 million versus the consensus estimate of $201.97 million.
For earnings history and earnings-related data on OPKO Health (OPK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SK Hynix could join the Nasdaq 100 if it expands its ADR float: Goldman
- Norfolk Southern (NSC) Tops Q3 EPS by 14c
- Comcast third-quarter earnings top estimates
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
